These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6123782)
1. Treatment of neuroleptic malignant syndrome with dantrolene. Goekoop JG; Carbaat PA Lancet; 1982 Jul; 2(8288):49-50. PubMed ID: 6123782 [No Abstract] [Full Text] [Related]
2. [Neuroleptic malignant syndrome. Beneficial effects of dantrolene on hyperthermia and hypertonia (author's transl)]. de Rohan Chabot P; Elkharrat D; Conso F; Bismuth C; Goulon M Nouv Presse Med; 1982 Mar; 11(14):1067-9. PubMed ID: 7079122 [No Abstract] [Full Text] [Related]
3. Beneficial effects of dantrolene in the treatment of neuroleptic malignant syndrome: a report of two cases. Goulon M; de Rohan-Chabot P; Elkharrat D; Gajdos P; Bismuth C; Conso F Neurology; 1983 Apr; 33(4):516-8. PubMed ID: 6682201 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome: response to dantrolene sodium. May DC; Morris SW; Stewart RM; Fenton BJ; Gaffney FA Ann Intern Med; 1983 Feb; 98(2):183-4. PubMed ID: 6824251 [No Abstract] [Full Text] [Related]
5. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene. Blank JW; Boggs SD J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973 [TBL] [Abstract][Full Text] [Related]
8. The neuroleptic malignant syndrome. A priority system. Neppe VM S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410 [TBL] [Abstract][Full Text] [Related]
9. [Masseter muscle rigidity after suxamethonium during induction and postoperative abortive malignant hyperthermia in a patient with esophageal achalasia]. Arakawa Y; Kuroiwa M; Anzai T; Kanai A; Okamoto H; Hoka S Masui; 2004 Mar; 53(3):287-90. PubMed ID: 15071881 [TBL] [Abstract][Full Text] [Related]
10. Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report. Khan A; Jaffe JH; Nelson WH; Morrison B J Clin Psychiatry; 1985 Jun; 46(6):244-6. PubMed ID: 3922961 [TBL] [Abstract][Full Text] [Related]
12. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Ward A; Chaffman MO; Sorkin EM Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659 [TBL] [Abstract][Full Text] [Related]
14. Rigidity and fever in two psychotic patients. Greenberg MS; Gorelick PB Hosp Pract (Off Ed); 1986 Jul; 21(7):171, 174. PubMed ID: 2873146 [No Abstract] [Full Text] [Related]
15. Video of dantrolene effectiveness on neuroleptic malignant syndrome associated muscular rigidity and tremor. Brvar M; Bunc M Crit Care; 2007; 11(3):415. PubMed ID: 17561987 [No Abstract] [Full Text] [Related]
16. A case of neuroleptic malignant syndrome successfully treated with amantadine. McCarron MM; Boettger ML; Peck JJ J Clin Psychiatry; 1982 Sep; 43(9):381-2. PubMed ID: 7118846 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of prolonged large-dose dantrolene for severe neuroleptic malignant syndrome. Tsujimoto S; Maeda K; Sugiyama T; Yokochi A; Chikusa H; Maruyama K Anesth Analg; 1998 May; 86(5):1143-4. PubMed ID: 9585314 [No Abstract] [Full Text] [Related]